sv3za
Registration
No. 333-163073
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Amendment No. 4
to
Form S-3
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
Sharps Compliance
Corp.
(Exact name of Registrant as
specified in its charter)
|
|
|
Delaware
|
|
74-2657168
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer Identification
No.)
|
9220 Kirby Drive, Suite 500
Houston, Texas 77054
(713) 432-0300
(Address, including zip
code, and telephone number,
including area code, of Registrants principal executive
offices)
|
|
David P. Tusa
9220 Kirby Drive, Suite 500
Houston, Texas 77054
(713) 432-0300
(Name, address, including
zip code, and telephone number,
including area code, of agent for service)
|
Copy to:
Fulbright & Jaworski L.L.P.
Fulbright Tower
1301 McKinney, Suite 5100
Houston, Texas 77010
(713) 651-5151
Attention: Gene G. Lewis
Approximate date of commencement of proposed sale to the
public: After this registration statement becomes
effective.
If the only securities being registered on this Form are being
offered pursuant to dividend or interest reinvestment plans,
please check the following
box. o
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest
reinvestment plans, check the following
box. o
If this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that
shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the
following
box. o
If this form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed
to register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities
Act, check the following
box. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
Large
accelerated
filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting
company þ
|
|
CALCULATION
OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
Proposed Maximum
|
|
|
Amount of
|
Title of Each Class of
|
|
|
Amount to be
|
|
|
Offering Price
|
|
|
Aggregate
|
|
|
Registration
|
Securities to be Registered
|
|
|
Registered(1)(2)
|
|
|
Per Share
|
|
|
Offering Price(3)
|
|
|
Fee(4)(5)
|
Common Stock, par value $0.01 per share
|
|
|
3,703,000 shares
|
|
|
$9.44
|
|
|
$34,956,320
|
|
|
$1,951
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Includes 483,000 shares of
common stock that the underwriters have the option to purchase
to cover over-allotments, if any.
|
(2)
|
|
Includes common stock issuable upon
exercise of options held by the selling stockholders.
|
(3)
|
|
Estimated solely for the purpose of
determining the registration fee.
|
(4)
|
|
Estimated solely for the purpose of
calculating the registration fee pursuant to Rule 457(c)
under the Securities Act of 1933, as amended. The calculation of
the registration fee is based on the average of the high and low
prices of the common stock as reported on The Nasdaq Capital
Market on November 9, 2009.
|
(5)
|
|
Previously paid.
|
The Registrant hereby amends this registration statement on
such date or dates as may be necessary to delay its effective
date until the Registrant shall file a further amendment which
specifically states that this registration statement shall
thereafter become effective in accordance with Section 8(a)
of the Securities Act of 1933 or until the registration
statement shall become effective on such date as the Commission,
acting pursuant to said Section 8(a), may determine.
EXPLANATORY NOTE
This Amendment No. 4 is being filed solely for the purpose of filing exhibit 5.1 to the
Registration Statement on Form S-3 (File No. 333-163073) and no changes or additions are being made
hereby to the prospectus which forms part of the Registration Statement or to Items 14, 15 or 17 of
Part II of the Registration Statement. Accordingly, the prospectus has been omitted from this
filing.
PART II
INFORMATION NOT
REQUIRED IN PROSPECTUS
|
|
Item 14.
|
Other
Expenses of Issuance and Distribution.
|
The following table sets forth the estimated expenses (other
than underwriting discounts and commissions) to be incurred by
the Company in connection with the issuance and distribution of
the shares of common stock being registered hereby, including
the shares being offered for sale by the selling stockholders.
Each selling stockholder will pay the portion of the SEC
registration fee and the FINRA filing fee and the underwriting
discounts and commissions associated with the common stock sold
by such selling stockholder pursuant to this registration
statement and such selling stockholders legal expenses.
|
|
|
|
|
SEC registration fee
|
|
$
|
1,951
|
|
FINRA filing fee
|
|
$
|
3,996
|
|
NASDAQ Capital Market listing fees
|
|
$
|
5,000
|
|
Printing expenses
|
|
$
|
10,000
|
|
Legal fees and expenses
|
|
$
|
250,000
|
|
Accounting fees and expenses
|
|
$
|
25,000
|
|
Miscellaneous expenses
|
|
$
|
4,053
|
|
|
|
|
|
|
Total
|
|
$
|
300,000
|
|
|
|
Item 15.
|
Indemnification
of Directors and Officers.
|
The discussion under the heading Description of Common
Stock Indemnification of Directors and
Officers in the prospectus is incorporated by reference
herein in its entirety.
The exhibits listed in the Exhibit Index are filed as part
of this registration statement.
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibit
|
|
|
1
|
.1*
|
|
Form of Underwriting Agreement.
|
|
3
|
.1
|
|
Bylaws of Company (incorporated by reference from
Exhibit 3.4 to
Form 10-KSB,
dated June 30, 1994).
|
|
3
|
.2
|
|
Amended and Restated Certificate of Incorporation of U.S.
Medical Systems, Inc. (incorporated by reference from
Exhibit 3.5 to the Registrants Transition Report on
Form 10KSB40 filed on September 29, 1998).
|
|
3
|
.3
|
|
Certificate of Elimination of the Series A 10% Voting
Convertible Preferred Stock of Sharps Compliance Corp.
(incorporated by reference from Exhibit 3.6 to
Form 10-KSB,
filed September 29, 1998).
|
|
4
|
.1
|
|
Specimen Stock Certificate (incorporated by reference from
Exhibit 4.4 to Form 10-KSB, filed September 29,
1998).
|
|
4
|
.2
|
|
See Exhibits 3.1, 3.2 and 3.3 for provisions of the Bylaws
of the Company, the Articles of Incorporation of the Company and
the Certificate of Elimination defining the rights of holders of
common shares.
|
|
5
|
.1
|
|
Opinion of Fulbright & Jaworski L.L.P.
|
|
23
|
.1*
|
|
Consent of UHY LLP.
|
|
23
|
.2
|
|
Consent of Fulbright & Jaworski L.L.P. (included in
Exhibit 5.1).
|
|
24
|
|
|
Power of Attorney (included in signature page).
|
II-1
The undersigned Registrant hereby undertakes that, for purposes
of determining any liability under the Securities Act, each
filing of the Registrants annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act
(and, where applicable, each filing of an employee benefit
plans annual report pursuant to Section 15(d) of the
Exchange Act) that is incorporated by reference in the
registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that
in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other
than the payment by the Registrant of expenses incurred or paid
by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant
will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final
adjudication of such issue.
The undersigned Registrant hereby undertakes that:
(1) For purposes of determining any liability under the
Securities Act, the information omitted from the form of
prospectus filed as part of this registration statement in
reliance upon Rule 430A and contained in a form of
prospectus filed by the registrant pursuant to
Rule 424(b)(1) or (4) or 497(h) under the Securities
Act shall be deemed to be part of this registration statement as
of the time it was declared effective.
(2) For the purpose of determining any liability under the
Securities Act, each post-effective amendment that contains a
form of prospectus shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
II-2
SIGNATURES AND
POWER OF ATTORNEY
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on
Form S-3
and has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the
City of Houston, State of Texas, on December 8, 2009.
Sharps Compliance Corp.
By:
/s/ Dr. Burton
J. Kunik
Dr. Burton J. Kunik
Chairman of the Board,
Chief Executive Officer and President
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated:
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Dr. Burton
J. Kunik
Dr. Burton
J. Kunik
|
|
Chairman of the Board, Chief Executive Officer and President
(Principal Executive Officer)
|
|
December 8, 2009
|
|
|
|
|
|
/s/ David
P. Tusa
David
P. Tusa
|
|
Executive Vice President, Chief Financial Officer and Business
Development (Principal Financial and Accounting Officer)
|
|
December 8, 2009
|
|
|
|
|
|
*
John
W. Dalton
|
|
Director
|
|
December 8, 2009
|
|
|
|
|
|
*
Ramsay
Gillman
|
|
Director
|
|
December 8, 2009
|
|
|
|
|
|
*
Parris
H. Holmes, Jr.
|
|
Director
|
|
December 8, 2009
|
|
|
|
|
|
*
F.
Gardner Parker
|
|
Director
|
|
December 8, 2009
|
|
|
|
|
|
*
Philip
C. Zerrillo
|
|
Director
|
|
December 8, 2009
|
|
|
|
|
|
|
|
*By:
|
|
/s/ David
P. Tusa
David
P. Tusa
Attorney-in-fact
|
|
|
|
|
II-3
EXHIBIT INDEX
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibit
|
|
|
1
|
.1*
|
|
Form of Underwriting Agreement.
|
|
3
|
.1
|
|
Bylaws of Company (incorporated by reference from
Exhibit 3.4 to
Form 10-KSB,
dated June 30, 1994).
|
|
3
|
.2
|
|
Amended and Restated Certificate of Incorporation of U.S.
Medical Systems, Inc. (incorporated by reference from
Exhibit 3.5 to the Registrants Transition Report on
Form 10KSB40 filed on September 29, 1998).
|
|
3
|
.3
|
|
Certificate of Elimination of the Series A 10% Voting
Convertible Preferred Stock of Sharps Compliance Corp.
(incorporated by reference from Exhibit 3.6 to
Form 10-KSB,
filed September 29, 1998).
|
|
4
|
.1
|
|
Specimen Stock Certificate (incorporated by reference from
Exhibit 4.4 to Form-10-KSB, filed September 29, 1998).
|
|
4
|
.2
|
|
See Exhibits 3.1, 3.2 and 3.3 for provisions of the Bylaws
of the Company, the Articles of Incorporation of the Company and
the Certificate of Elimination defining the rights of holders of
common shares.
|
|
5
|
.1
|
|
Opinion of Fulbright & Jaworski L.L.P.
|
|
23
|
.1*
|
|
Consent of UHY LLP.
|
|
23
|
.2
|
|
Consent of Fulbright & Jaworski L.L.P. (included in
Exhibit 5.1).
|
|
24
|
|
|
Power of Attorney (included in signature page).
|
II-4